<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR23">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Takayama</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Nagashima</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Maeda</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Nojiri</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Hirayama</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Nakano</surname>
    <given-names>Y</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Randomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polyps</article-title>
  <source>Clin Cancer Res</source>
  <year>2011</year>
  <volume>17</volume>
  <issue>11</issue>
  <fpage>3803</fpage>
  <lpage>11</lpage>
  <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-10-2395</pub-id>
  <pub-id pub-id-type="pmid">21385928</pub-id>
 </element-citation>
</ref>
